Founded by seasoned US and Canadian investors with extensive capital market experience and prominent biopharma executives. Collectively, the team has invested and managed hundreds of millions in working capital and have a strong track record of investing and building companies in the life sciences sector.

Leveraging our business acumen, we seek to identify early-stage companies with the leadership expertise to deliver solutions that can profoundly address global unmet needs.

Our approach to creating intrinsic value is to clear the runway for long-term growth – without taking any shortcuts.

We put capital to work in companies developing cutting-edge technology that have the potential to redefine the future of healthcare.